{"id":"W2790178001","doi":"10.1016/j.euroneuro.2018.01.003","title":"The safety, tolerability and pharmacokinetics of BI 409306, a novel and potent PDE9 inhibitor: Overview of three Phase I randomised trials in healthy volunteers","year":2018,"lang":"en","type":"article","venue":"European Neuropsychopharmacology","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Tolerability; Pharmacokinetics; Medicine; Pharmacology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005311896,0.001199463,0.003845595,0.0005777483,0.000399662,0.001009955,0.000774693,0.001461399,0.002938301],"category_scores_gemma":[0.003258476,0.0007680734,0.003057849,0.001397216,0.0006551167,0.0009261902,0.0003838706,0.002017641,0.0004688882],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007666207,"about_ca_system_score_gemma":0.001053045,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009241936,"about_ca_topic_score_gemma":0.003103288,"domain_scores_codex":[0.9982741,0.0009915,0.0002497946,0.0002058897,0.0001671294,0.0001116471],"domain_scores_gemma":[0.9983065,0.0006933751,0.0005026086,0.00009834703,0.0001882955,0.0002109164],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6795161,0.003806507,0.003615255,0.0228,0.0130522,0.0002025605,0.000352314,0.001466151,0.02473457,0.0005759832,0.004366731,0.2455116],"study_design_scores_gemma":[0.7145009,0.2121952,0.02083479,0.001852923,0.02106745,0.0009239464,0.0002245177,0.0009851354,0.004676474,0.001056399,0.02151003,0.0001721701],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5203205,0.4483279,0.006395883,0.002764537,0.0005820839,0.01079609,0.004494828,0.0004549462,0.005863351],"genre_scores_gemma":[0.6624297,0.3076206,0.009296824,0.003180207,0.000569415,0.008810441,0.00446995,0.0001358467,0.003486936],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005311896,"threshold_uncertainty_score":0.02809232,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04762401999318396,"score_gpt":0.3513778516943073,"score_spread":0.3037538317011234,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}